DYAI - DYADIC INTERNATIONAL INC
1.09
-0.030 -2.752%
Share volume: 49,964
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.12
-0.03
-0.03%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-10-2023 | 08-09-2023 | 11-08-2023 | 03-28-2024 | 05-14-2024 | 08-13-2024 | 11-12-2024 | 03-26-2025 | |
Total revenue | 978.052 K | 837.159 K | 397.060 K | 686.535 K | 334.617 K | 385.896 K | 1.958 M | 817.376 K | |
Cost of revenue | 726.918 K | 792.944 K | 105.869 K | 350.118 K | 143.955 K | 301.956 K | 395.894 K | 352.819 K | |
Gross profit | 251.134 K | 44.215 K | 291.191 K | 336.417 K | 190.662 K | 83.940 K | 1.562 M | 464.557 K | |
-82.39% | 558.58% | 15.53% | -43.33% | -55.97% | 1,760.38% | -70.25% | |||
Operating expenses | 2.291 M | 2.320 M | 1.999 M | 2.505 M | 2.311 M | 2.123 M | 1.758 M | 1.986 M | |
Selling general and admin | 1.480 M | 1.403 M | 1.282 M | 1.652 M | 1.789 M | 1.608 M | 1.298 M | 1.440 M | |
Research and development | 810.566 K | 917.552 K | 716.351 K | 852.797 K | 522.723 K | 515.629 K | 460.241 K | 545.660 K | |
Total expenses | 3.018 M | 3.113 M | 2.105 M | 2.855 M | 2.316 M | 2.127 M | 1.764 M | 1.995 M | |
3.17% | -32.40% | 35.65% | -18.87% | -8.19% | -17.04% | 13.06% | |||
Operating income | -2.039 M | -2.276 M | -1.708 M | -2.168 M | -2.126 M | -2.043 M | -202.614 K | -1.530 M | |
Ebit | -2.039 M | -2.276 M | -1.708 M | -2.168 M | -2.126 M | -2.043 M | -202.614 K | -1.530 M | |
Pretax income | -956.444 K | -2.153 M | -1.614 M | -2.072 M | -2.010 M | -2.045 M | -203.460 K | -1.551 M | |
125.10% | -25.02% | 28.34% | -3.00% | 1.77% | -90.05% | 662.25% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -956.444 K | -2.153 M | -1.614 M | -2.072 M | 0.000 | 0.000 | 0.000 | 0.000 | |
-125.10% | 25.02% | -28.34% | 100.00% | ||||||
Net income | -956.444 K | -2.153 M | -1.614 M | -2.072 M | -2.010 M | -2.045 M | -203.460 K | -1.551 M | |
-125.10% | 25.02% | -28.34% | 3.00% | -1.77% | 90.05% | -662.25% |